Diabetic Retinopathy: OCT Assessment

Diabetic macular edema is the leading cause of vision loss in working-age adults worldwide. OCT is the gold standard for DME detection, monitoring, and treatment response assessment — finding fluid accumulation that's invisible on clinical exam.

Why OCT Changes DR Management: OCT detects subclinical DME months before it's visible on funduscopy. Early detection means earlier treatment, better visual outcomes, and documentation that supports CPT 92134 billing.

DME Patterns on OCT

DME patterns: diffuse spongiform, cystoid pseudocysts, SRF — Educational illustration, not a clinical scan

🔭 Clinical Reference — CC BY 4.0

OCT B-scan showing diabetic macular edema with hard exudates and intraretinal cysts

Diabetic macular edema (DME) on OCT (Fig.4). Retinal thickening, hyperreflective foci (hard exudates), intraretinal cystoid spaces, and DRIL (disorganisation of retinal inner layers). DRIL is the strongest OCT predictor of poor visual acuity in DME. — Kulyabin M et al. Sci Data 11:365 (2024), CC BY 4.0

Not all DME looks the same — the fluid pattern has clinical and prognostic implications:

DME Pattern	OCT Appearance	Visual Prognosis	Typical Response to Anti-VEGF
Diffuse thickening	Retinal thickening without distinct cysts; spongiform appearance	Variable	Good
Cystoid spaces (CME)	Distinct hypo-reflective spaces in ONL/INL; "Swiss cheese" on en face	Good if EZ intact	Good
Subfoveal SRF	Fluid between EZ and RPE	Worse if chronic	Moderate
Disorganized inner retina (DRIL)	Loss of distinct layer boundaries in inner retina	Poor	Limited
Hard exudate deposits	Hyperreflective foci with posterior shadowing	Poor if subfoveal	Slow/poor

The EZ Band: Your Most Valuable Measurement

EZ band intact = good prognosis, disrupted = guarded VA outcome — Educational illustration, not a clinical scan

In DR, the ellipsoid zone is the best single indicator of photoreceptor health and visual prognosis:

Intact EZ: Good functional reserve, favorable prognosis even with significant edema
Disrupted EZ: Photoreceptor damage — vision may not recover even if fluid resolves
EZ disruption length: Measured in μm at the foveal center; >500 μm disruption predicts poor visual acuity outcomes

Clinical Principle: VA alone doesn't tell you the full story. A patient with DME and 20/40 vision but an intact EZ will likely recover to 20/20 with treatment. A patient with DME and 20/40 vision but disrupted EZ may not improve above 20/40 despite complete fluid resolution. OCT tells you which patient you're treating.

Hyperreflective Foci (HRF) in DR

HRF in DR: intraretinal lipid vs outer retinal severity marker — Educational illustration, not a clinical scan

Small, bright dots throughout the retina in DR represent several pathological processes:

Migrating RPE cells (in later DR)
Precursors to hard exudate crystalline lipid deposits
Inflammatory microglial cells
Lipid-laden macrophages

HRF in the outer nuclear layer predict progression to hard exudate deposits and are associated with worse visual outcomes. HRF count and distribution is an emerging biomarker for DME severity.

DR Staging on OCT: Beyond the Fundus Exam

Center-involving vs non-center DME based on CST — Educational illustration, not a clinical scan

OCT changes DR staging in two critical ways:

Subclinical edema detection: Central subfield thickness (CST) >305 μm in men or >290 μm in women (Zeiss Cirrus thresholds) defines center-involving DME — regardless of what you see on slit lamp. The OCT finding determines treatment eligibility, not the clinical appearance.
Ischemia assessment: Inner retinal thinning on en face imaging correlates with diabetic ischemia (non-perfusion). Areas of inner retinal atrophy on structural en face often correspond to non-perfusion zones on OCTA.

En Face DME: The Cyst Map

En face cyst map: pericentral DME distribution, FAZ assessment — Educational illustration, not a clinical scan

On en face imaging at the inner retinal slab (spanning ONL and INL), cystoid DME produces a characteristic dark-on-bright pattern: cysts appear as dark holes against the brighter retinal background. En face gives you:

Total cyst volume (better than CST alone for treatment monitoring)
Geographic distribution of fluid — central vs. paracentral pattern
Asymmetry that predicts which area will respond first to treatment

DME Monitoring Protocol

DME monitoring: annual to monthly based on severity — Educational illustration, not a clinical scan

DR Severity + DME Status	OCT Frequency	Action Threshold
Mild/Moderate NPDR, no DME	Annual	CST increase >10% from baseline
Severe NPDR, no DME	Every 3–4 months	Any new fluid
Non-center-involving DME	Every 3 months	Progression toward center
Center-involving DME (untreated)	Monthly until stable	Refer for treatment
Active treatment	Per protocol	Per DRCR protocols

Key Takeaways

OCT detects DME before funduscopy — rely on CST measurements, not clinical appearance alone
EZ band integrity is the most important predictor of visual outcome in DME
DRIL (disorganized inner retina) predicts poor functional recovery
En face inner retinal slab maps cyst distribution and volume beyond CST alone
HRF in the outer retina predict hard exudate deposits and worse prognosis

Educational illustration — Diabetic Macular Edema: intraretinal fluid cysts (blue) with hyperreflective foci (amber). Real clinical scans in full course.

Create Free Account

In This Course

1. Retinal Layer Anatomy & Normal Findings 2. B-Scan Interpretation Fundamentals 3. Introduction to En Face Views 4. AMD: OCT Findings & En Face Correlation 5. Diabetic Retinopathy: OCT Assessment 6. RVO & CSC: Basic OCT Patterns 7. ERM & Macular Hole: Surgical Decision Points